Analysis

Gain Therapeutics, Inc. (GANX) Stock Analysis

Gain Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to GANX.

websiteGANX/analysis/GANX

Gain Therapeutics, Inc.

Gain Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to GANX.

Stock profile

Ticker

GANX

Asset type

Stock

Market cap

$80.2M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Gain Therapeutics, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • GANX primary listing

Latest Gain Therapeutics, Inc. news

Gain Therapeutics to Present at H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit

BETHESDA, Md., June 10, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery ...

Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026

Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026

Gain Therapeutics Reports Financial Results for First Quarter 2026 and Provides Corporate Update

BETHESDA, Md., May 11, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery a...

Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026

BETHESDA, Md., April 24, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company

Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update

BETHESDA, Md., March 26, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company

Research sections

Valuation

Review valuation context for Gain Therapeutics, Inc..

Future growth

Review future growth context for Gain Therapeutics, Inc..

Past performance

Review past performance context for Gain Therapeutics, Inc..

Financial health

Review financial health context for Gain Therapeutics, Inc..

Dividend

Review dividend context for Gain Therapeutics, Inc..

Management

Review management context for Gain Therapeutics, Inc..

Ownership

Review ownership context for Gain Therapeutics, Inc..

Other information

Review other information context for Gain Therapeutics, Inc..

Community

Review community context for Gain Therapeutics, Inc..